** Shares in DSM DSMN.AS rise 2.5% after the Dutch
specialty chemicals maker published Q4 results above market
expectations urn:newsml:reuters.com:*:nL1N2UQ0AC
** The group reported Q4 EBITDA up 13% YoY at EUR 440 mln
($498.70 mln), 3.8% above consensus, while revenue rose 16% to
EUR 2.4 bln
** DSM expects for 2022 a mid-single digit adjusted EBITDA
increase, with a high-single digit adjusted net operating free
cash flow increase
** JP Morgan calls the 2022 guidance "reassuring"
** DSM also maintains its mid-term profit targets
** Shares are on track for their best day since December 7,
2021
($1 = 0.8823 euros)
(Reporting by Olivier Cherfan)
((olivier.cherfan@thomsonreuters.com))